世界のグリコシル化バイオシミラー市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20DC4199)
◆英語タイトル:Global Glycosylated Biosimilars Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20DC4199
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年12月(※2024年版があります。お問い合わせください。)
◆ページ数:108
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、グリコシル化バイオシミラーの世界市場を広く調査・分析し、今後の市場展望をまとめております。グリコシル化バイオシミラーの種類別市場規模(mAb、EPO)、用途別市場規模(腫瘍、慢性疾患、自己免疫疾患、血液疾患、成長ホルモン欠乏症、感染症、その他の疾患)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Sandoz、Mylan、Celltrion、Pfizer、Samsung Biologics、Teva Pahrmaceutical、Stada Arzneimittel AG、Amgen、Biocon、Dr. Reddy's Laboratories、
・地域別グローバル市場分析 2015年-2020年
・グリコシル化バイオシミラーの北米市場(アメリカ、カナダ、メキシコ)
・グリコシル化バイオシミラーのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・グリコシル化バイオシミラーのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・グリコシル化バイオシミラーの南米市場(ブラジル、アルゼンチン)
・グリコシル化バイオシミラーの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:mAb、EPO
・用途別分析:腫瘍、慢性疾患、自己免疫疾患、血液疾患、成長ホルモン欠乏症、感染症、その他の疾患
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The global Glycosylated Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Glycosylated Biosimilars market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Glycosylated Biosimilars market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Glycosylated Biosimilars market has been segmented into
mAb
EPO

By Application, Glycosylated Biosimilars has been segmented into:
Oncology
Chronic Diseases
Autoimmune Diseases
Blood Disorders
Growth Hormone Deficiency
Infectious Diseases
Other Diseases

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Glycosylated Biosimilars market presented in the report. This section sheds light on the sales growth of different regional and country-level Glycosylated Biosimilars markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Glycosylated Biosimilars market.

The report offers in-depth assessment of the growth and other aspects of the Glycosylated Biosimilars market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Glycosylated Biosimilars Market Share Analysis
Glycosylated Biosimilars competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Glycosylated Biosimilars sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Glycosylated Biosimilars sales, revenue and market share for each player covered in this report.

The major players covered in Glycosylated Biosimilars are:
Sandoz
Mylan
Celltrion
Pfizer
Samsung Biologics
Teva Pahrmaceutical
Stada Arzneimittel AG
Amgen
Biocon
Dr. Reddy’s Laboratories

Among other players domestic and global, Glycosylated Biosimilars market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glycosylated Biosimilars product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Glycosylated Biosimilars, with price, sales, revenue and global market share of Glycosylated Biosimilars in 2018 and 2019.
Chapter 3, the Glycosylated Biosimilars competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glycosylated Biosimilars breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Glycosylated Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Glycosylated Biosimilars sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Glycosylated Biosimilars Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Glycosylated Biosimilars Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 mAb
1.2.3 EPO
1.3 Market Analysis by Application
1.3.1 Overview: Global Glycosylated Biosimilars Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Chronic Diseases
1.3.4 Autoimmune Diseases
1.3.5 Blood Disorders
1.3.6 Growth Hormone Deficiency
1.3.7 Infectious Diseases
1.3.8 Other Diseases
1.4 Overview of Global Glycosylated Biosimilars Market
1.4.1 Global Glycosylated Biosimilars Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sandoz
2.1.1 Sandoz Details
2.1.2 Sandoz Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sandoz SWOT Analysis
2.1.4 Sandoz Product and Services
2.1.5 Sandoz Glycosylated Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mylan SWOT Analysis
2.2.4 Mylan Product and Services
2.2.5 Mylan Glycosylated Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Celltrion
2.3.1 Celltrion Details
2.3.2 Celltrion Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Celltrion SWOT Analysis
2.3.4 Celltrion Product and Services
2.3.5 Celltrion Glycosylated Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Glycosylated Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Samsung Biologics
2.5.1 Samsung Biologics Details
2.5.2 Samsung Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Samsung Biologics SWOT Analysis
2.5.4 Samsung Biologics Product and Services
2.5.5 Samsung Biologics Glycosylated Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teva Pahrmaceutical
2.6.1 Teva Pahrmaceutical Details
2.6.2 Teva Pahrmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teva Pahrmaceutical SWOT Analysis
2.6.4 Teva Pahrmaceutical Product and Services
2.6.5 Teva Pahrmaceutical Glycosylated Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Stada Arzneimittel AG
2.7.1 Stada Arzneimittel AG Details
2.7.2 Stada Arzneimittel AG Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Stada Arzneimittel AG SWOT Analysis
2.7.4 Stada Arzneimittel AG Product and Services
2.7.5 Stada Arzneimittel AG Glycosylated Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Amgen SWOT Analysis
2.8.4 Amgen Product and Services
2.8.5 Amgen Glycosylated Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Biocon
2.9.1 Biocon Details
2.9.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Biocon SWOT Analysis
2.9.4 Biocon Product and Services
2.9.5 Biocon Glycosylated Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Dr. Reddy’s Laboratories
2.10.1 Dr. Reddy’s Laboratories Details
2.10.2 Dr. Reddy’s Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Dr. Reddy’s Laboratories SWOT Analysis
2.10.4 Dr. Reddy’s Laboratories Product and Services
2.10.5 Dr. Reddy’s Laboratories Glycosylated Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Glycosylated Biosimilars Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Glycosylated Biosimilars Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Glycosylated Biosimilars Manufacturer Market Share in 2019
3.3.2 Top 6 Glycosylated Biosimilars Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Glycosylated Biosimilars Sales, Revenue and Market Share by Regions
4.1.1 Global Glycosylated Biosimilars Sales and Market Share by Regions (2015-2020)
4.1.2 Global Glycosylated Biosimilars Revenue and Market Share by Regions (2015-2020)
4.2 North America Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
4.3 Europe Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
4.5 South America Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Glycosylated Biosimilars Sales, Revenue and Market Share by Country
5.1.1 North America Glycosylated Biosimilars Sales and Market Share by Country (2015-2020)
5.1.2 North America Glycosylated Biosimilars Revenue and Market Share by Country (2015-2020)
5.2 United States Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
5.3 Canada Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
5.4 Mexico Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Glycosylated Biosimilars Sales, Revenue and Market Share by Country
6.1.1 Europe Glycosylated Biosimilars Sales and Market Share by Country (2015-2020)
6.1.2 Europe Glycosylated Biosimilars Revenue and Market Share by Country (2015-2020)
6.2 Germany Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
6.3 UK Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
6.4 France Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
6.5 Russia Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
6.6 Italy Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Glycosylated Biosimilars Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Glycosylated Biosimilars Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Glycosylated Biosimilars Revenue and Market Share by Regions (2015-2020)
7.2 China Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
7.3 Japan Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
7.4 Korea Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
7.5 India Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
7.7 Australia Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Glycosylated Biosimilars Sales, Revenue and Market Share by Country
8.1.1 South America Glycosylated Biosimilars Sales and Market Share by Country (2015-2020)
8.1.2 South America Glycosylated Biosimilars Revenue and Market Share by Country (2015-2020)
8.2 Brazil Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
8.3 Argentina Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Glycosylated Biosimilars Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Glycosylated Biosimilars Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Glycosylated Biosimilars Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
9.3 Turkey Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
9.4 Egypt Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
9.5 South Africa Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Glycosylated Biosimilars Sales and Market Share by Type (2015-2020)
10.2 Global Glycosylated Biosimilars Revenue and Market Share by Type (2015-2020)
10.3 Global Glycosylated Biosimilars Price by Type (2015-2020)
11 Global Glycosylated Biosimilars Market Segment by Application
11.1 Global Glycosylated Biosimilars Sales Market Share by Application (2015-2020)
11.2 Global Glycosylated Biosimilars Revenue Market Share by Application (2015-2020)
11.3 Global Glycosylated Biosimilars Price by Application (2015-2020)
12 Market Forecast
12.1 Global Glycosylated Biosimilars Sales, Revenue and Growth Rate (2021-2025)
12.2 Glycosylated Biosimilars Market Forecast by Regions (2021-2025)
12.2.1 North America Glycosylated Biosimilars Market Forecast (2021-2025)
12.2.2 Europe Glycosylated Biosimilars Market Forecast (2021-2025)
12.2.3 Asia-Pacific Glycosylated Biosimilars Market Forecast (2021-2025)
12.2.4 South America Glycosylated Biosimilars Market Forecast (2021-2025)
12.2.5 Middle East & Africa Glycosylated Biosimilars Market Forecast (2021-2025)
12.3 Glycosylated Biosimilars Market Forecast by Type (2021-2025)
12.3.1 Global Glycosylated Biosimilars Sales Forecast by Type (2021-2025)
12.3.2 Global Glycosylated Biosimilars Market Share Forecast by Type (2021-2025)
12.4 Glycosylated Biosimilars Market Forecast by Application (2021-2025)
12.4.1 Global Glycosylated Biosimilars Sales Forecast by Application (2021-2025)
12.4.2 Global Glycosylated Biosimilars Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【掲載企業】

Sandoz、Mylan、Celltrion、Pfizer、Samsung Biologics、Teva Pahrmaceutical、Stada Arzneimittel AG、Amgen、Biocon、Dr. Reddy's Laboratories、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のグリコシル化バイオシミラー市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Glycosylated Biosimilars Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。